Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable ...

Researchers have identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in ...

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate ...

Scientists have discovered novel drug candidates that could ultimately lead to new effective treatments for conditions caused ...

Researchers have developed a new optical chip capable of transmitting 1,000 gigabits per second – orders of magnitude above ...

Scientists have produced a new roadmap outlining how genetic changes can affect the oil production of plants commonly used to ...

The results offer real-world data that support long-term protection through vaccination and suggest a level of population ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

The FDA has released 200+ complete response letters in a bid to offer new insights into drug approval rejections and ...

The findings have sparked concern among the fishery’s many stakeholders and highlight a need for new tools that can help ...

Adults who stay consistently active throughout their lives can lower their risk of early death by up to 40 percent, a global ...